OBJECTIVE: To explore the correlation between @entity27 ( @entity27 ) and @entity66 ( @entity66 ). METHODS: A cohort of 1868 @entity1 was screened for @entity27 , and followed from November 1989 to November 2009. Annual medical examinations including blood pressure, blood fat, serum @entity413 , electrocardiogram and chest x-ray were performed. Computer tomography was carried out when @entity66 , the endpoint of the study, was manifested. RESULTS: Among the 1868 elderly @entity1 , 598 (32.0%) were confirmed to have @entity27 , including 496 (82.9%) males and 102 (17.1%) females. Compared with the non- @entity27 group, @entity1 with @entity27 had more symptoms including daytime @entity2147 , @entity10 , decreased ability of memory, aphronesia and allolalia (P < 0.05). @entity66 occurred in 276 (46.2%) @entity1 of the @entity27 group, but in 150 (11.8%, P < 0.01) subjects of the non- @entity27 group. During the 20-year follow-up, 817 @entity1 died, 66.2% (396/598) in the @entity27 group, but 33.1% (421/1270) in the non- @entity27 group (P < 0.01). CONCLUSION: @entity1 with @entity27 are more likely to suffer from @entity66 . @entity27 may be an independent risk factor for @entity66 .

[Twenty years follow-up: the correlation between sleep apnea syndrome and XXXX ].

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'people'] @entity66 :: ('MESH:D004194', 'Disease') :: ['CVD', 'cerebrovascular disease'] @entity27 :: ('MESH:D020181', 'Disease') :: ['OSAS', 'obstructive sleep apnea syndrome'] @entity2147 :: ('MESH:D006970', 'Disease') :: ['somnolence'] @entity10 :: ('MESH:D006261', 'Disease') :: ['headache'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose']
@entity66 :: (MESH:D004194,Disease) :: ['cerebrovascular disease']
